Assessment of Early Post-operative Nuclear Imaging in Neurosurgery: a Safety and Feasibility Study in Patients Operated for Glioblastoma

Recruiting N/A Interventional Study
Glioblastoma Brain Tumors Brain Imaging
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
15 (estimated)
Sponsor
Beta Emitting Accurate Monitored Systems · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This clinical trial aims to evaluate the feasibility and safety of early post-operative brain PET-MRI imaging in adult patients who have undergone surgery for suspected glioblastoma. The study also seeks to validate specific nuclear imaging parameters for better detection of residual tumor tissue compared to standard gadolinium-enhanced MRI. The main objectives are to determine whether early PET-M…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * First resection for a suspected glioblastoma in the past 72h * Signed informed consent non-inclusion Criteria: * Deprived of liberty or under legal protection (e.g, guardianship, trusteeship) * Patients under 18 years old * Absence of social security cover * Pregnancy * Emer…
Contacts

Caroline Apra, MD, PhD

+330149812240

contact@beams.bio

CONTACT

Nawel Saci, Msc

+33667405900

nawelsaci@olexclinical.com

CONTACT